Diagnostics and Pharmacotherapy for Severe Forms of TB (DMID 15-0100)

CompletedOBSERVATIONAL
Enrollment

478

Participants

Timeline

Start Date

April 28, 2016

Primary Completion Date

July 31, 2020

Study Completion Date

January 31, 2021

Conditions
Tuberculosis
All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

collaborator

Scientific Center for Family Health and Human Reproduction Problems, Russia

OTHER_GOV

collaborator

Kilimanjaro Christian Medical Centre, Tanzania

OTHER

collaborator

Haydom Lutheran Hospital

OTHER

collaborator

Mbarara University of Science and Technology

OTHER

collaborator

International Centre for Diarrhoeal Disease Research, Bangladesh

OTHER

collaborator

University of Florida

OTHER

lead

University of Virginia

OTHER

NCT03559582 - Diagnostics and Pharmacotherapy for Severe Forms of TB (DMID 15-0100) | Biotech Hunter | Biotech Hunter